Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18
Rates do not apply to holidays, Easter, long weekends, national holidays, Christmas or New Years
Retatrutide is currently in phase 3 clinical trials and has not yet been approved by the FDA
Published studies used different routes, including oral and intravenous administration, so the amounts cannot be directly transferred between routes
Older Adults: As we age, stomach acid production can decrease, making B12 absorption more challenging
Always speak with your doctor before taking any new supplements if you have kidney disease
Composition AOD 9604: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment via HPLC/LC-MS Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation COA pending third-party verification in progress Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA (HPLC/LC-MS) with verification key Third-party verification link provided per lot (Janoshik) Lyophilized for transit stability
US$ 21.21
US$ 24.53
US$ 25.47
